In Vivo 7T MR Quantitative Susceptibility Mapping Reveals Opposite Susceptibility Contrast between Cortical and White Matter Lesions in Multiple Sclerosis

References

1. 1.↵
   2. Calabrese M,
   3. Filippi M,
   4. Gallo P

   . Cortical lesions in multiple sclerosis. Nat Rev Neurol 2010;6:438–44 doi:10.1038/nrneurol.2010.93 pmid:20625376

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Harrison DM,
   3. Roy S,
   4. Oh J, et al

   . Association of cortical lesion burden on 7-T magnetic resonance imaging with cognition and disability in multiple sclerosis. JAMA Neurol 2015;72:1004–12 doi:10.1001/jamaneurol.2015.1241 pmid:26192316

   CrossRefPubMed
3. 3.↵
   2. Peterson JW,
   3. Bo L,
   4. Mörk S, et al

   . Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001;50:389–400 doi:10.1002/ana.1123 pmid:11558796

   CrossRefPubMedWeb of Science
4. 4.↵
   2. van Horssen J,
   3. Brink BP,
   4. de Vries HE, et al

   . The blood-brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol 2007;66:321–28 doi:10.1097/nen.0b013e318040b2de pmid:17413323

   Abstract/FREE Full Text
5. 5.↵
   2. Louapre C,
   3. Lubetzki C

   . Neurodegeneration in multiple sclerosis is a process separate from inflammation: yes. Mult Scler 2015;21:1626–28 doi:10.1177/1352458515587598 pmid:26515289

   FREE Full Text
6. 6.↵
   2. Bagnato F,
   3. Hametner S,
   4. Yao B, et al

   . Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain 2011;134:3602–15 doi:10.1093/brain/awr278 pmid:22171355

   Abstract/FREE Full Text
7. 7.↵
   2. Yao B,
   3. Bagnato F,
   4. Matsuura E, et al

   . Chronic multiple sclerosis lesions: characterization with high-field-strength MR imaging. Radiology 2012;262:206–15 doi:10.1148/radiol.11110601 pmid:22084205

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Wisnieff C,
   3. Ramanan S,
   4. Olesik J, et al

   . Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: interpreting positive susceptibility and the presence of iron. Magn Reson Med 2015;74:564–70 doi:10.1002/mrm.25420 pmid:25137340

   CrossRefPubMed
9. 9.↵
   2. Chen W,
   3. Gauthier SA,
   4. Gupta A, et al

   . Quantitative susceptibility mapping of multiple sclerosis lesions at various ages. Radiology 2014;271:183–92 doi:10.1148/radiol.13130353 pmid:24475808

   CrossRefPubMed
10. 10.↵
    2. Yao B,
    3. Hametner S,
    4. van Gelderen P, et al

    . 7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis. PLoS One 2014;9:e108863 doi:10.1371/journal.pone.0108863 pmid:25303286

    CrossRefPubMed
11. 11.↵
    2. Mainero C,
    3. Louapre C,
    4. Govindarajan ST, et al

    . A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging. Brain 2015;138:932–45 doi:10.1093/brain/awv011 pmid:25681411

    Abstract/FREE Full Text
12. 12.↵
    2. Louapre C,
    3. Govindarajan ST,
    4. Gianni C, et al

    . Beyond focal cortical lesions in MS: an in vivo quantitative and spatial imaging study at 7T. Neurology 2015;85:1702–09 doi:10.1212/WNL.0000000000002106 pmid:26468411

    Abstract/FREE Full Text
13. 13.↵
    2. Jonkman LE,
    3. Fleysher L,
    4. Steenwijk MD, et al

    . Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis. Mult Scler 2015 Dec 16. [Epub ahead of print] pmid:26672996
14. 14.↵
    2. Deh K,
    3. Nguyen TD,
    4. Eskreis-Winkler S, et al

    . Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors. J Magn Reson Imaging 2015;42:1592–600 doi:10.1002/jmri.24943 pmid:25960320

    CrossRefPubMed
15. 15.↵
    2. Wang Y,
    3. Liu T

    . Quantitative susceptibility mapping (QSM): decoding MRI data for a tissue magnetic biomarker. Magn Reson Med 2015;73:82–101 doi:10.1002/mrm.25358 pmid:25044035

    CrossRefPubMed
16. 16.↵
    2. Liu C,
    3. Li W,
    4. Tong KA, et al

    . Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain. J Magn Reson Imaging 2015;42:23–41 doi:10.1002/jmri.24768 pmid:25270052

    CrossRefPubMed
17. 17.↵
    2. McDonald WI,
    3. Compston A,
    4. Edan G, et al

    . Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121–27 doi:10.1002/ana.1032 pmid:11456302

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Saranathan M,
    3. Tourdias T,
    4. Bayram E, et al

    . Optimization of white-matter-nulled magnetization prepared rapid gradient echo (MP-RAGE) imaging. Magn Reson Med 2015;73:1786–94 doi:10.1002/mrm.25298 pmid:24889754

    CrossRefPubMed
19. 19.↵
    2. Saranathan M,
    3. Tourdias T,
    4. Kerr AB, et al

    . Optimization of magnetization-prepared 3-dimensional fluid attenuated inversion recovery imaging for lesion detection at 7 T. Invest Radiol 2014;49:290–98 doi:10.1097/RLI.0000000000000041 pmid:24566291

    CrossRefPubMed
20. 20.↵
    2. Liu J,
    3. Liu T,
    4. de Rochefort L, et al

    . Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map. Neuroimage 2012;59:2560–68 doi:10.1016/j.neuroimage.2011.08.082 pmid:21925276

    CrossRefPubMed
21. 21.↵
    2. Smith SM,
    3. Jenkinson M,
    4. Woolrich MW, et al

    . Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1):S208–19 doi:10.1016/j.neuroimage.2004.07.051 pmid:15501092

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Wisnieff C,
    3. Ryan R,
    4. Pitt D, et al

    . Investigation of susceptibility contrast in grey and white matter multiple sclerosis lesions. In: Proceedings of the Annual Scientific Meeting of the International Society for Magnetic Resonance in Medicine, Milan, Italy. May 10–16, 2014
23. 23.↵
    2. Li X,
    3. Harrison DM,
    4. Liu H, et al

    . Magnetic susceptibility contrast variations in multiple sclerosis lesions. J Magn Reson Imaging 2016;43:463–73 doi:10.1002/jmri.24976 pmid:26073973

    CrossRefPubMed
24. 24.↵
    2. Mehta V,
    3. Pei W,
    4. Yang G, et al

    . Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. PLoS One 2013;8:e57573 doi:10.1371/journal.pone.0057573 pmid:23516409

    CrossRefPubMed
25. 25.↵
    2. Hametner S,
    3. Wimmer I,
    4. Haider L, et al

    . Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol 2013;74:848–61 doi:10.1002/ana.23974 pmid:23868451

    CrossRefPubMed
26. 26.↵
    2. Chari DM

    . Remyelination in multiple sclerosis. Int Rev Neurobiol 2007;79:589–620 doi:10.1016/S0074-7742(07)79026-8 pmid:17531860

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Pitt D,
    3. Boster A,
    4. Pei W, et al

    . Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging. Arch Neurol 2010;67:812–18 doi:10.1001/archneurol.2010.148 pmid:20625086

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Haacke EM,
    3. Cheng NY,
    4. House MJ, et al

    . Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005;23:1–25 doi:10.1016/j.mri.2004.10.001 pmid:15733784

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Fukunaga M,
    3. Li TQ,
    4. van Gelderen P, et al

    . Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc Natl Acad Sci U S A 2010;107:3834–39 doi:10.1073/pnas.0911177107 pmid:20133720

    Abstract/FREE Full Text
30. 30.↵
    2. Langkammer C,
    3. Krebs N,
    4. Goessler W, et al

    . Susceptibility induced gray-white matter MRI contrast in the human brain. Neuroimage 2012;59:1413–19 doi:10.1016/j.neuroimage.2011.08.045 pmid:21893208

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Bian W,
    3. Harter K,
    4. Hammond-Rosenbluth KE, et al

    . A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis. Mult Scler 2013;19:69–75 doi:10.1177/1352458512447870 pmid:22641301

    Abstract/FREE Full Text